Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas. Reimann M, Schrezenmeier J, Richter-Pechanska P, Dolnik A, et al. Blood 2021;137:2785-2799.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Reimann M, Schrezenmeier J, Richter-Pechanska P, Dolnik A, et al. Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas. Blood 2021;137:2785-2799.
PMID: 33232972